다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

EPIX

ESSA Pharma (EPIX)

ESSA Pharma Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:EPIX

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/14	20:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EPIX	ESSA Pharma Inc
2024/05/14	20:00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:EPIX	ESSA Pharma Inc
2024/05/14	20:00	PR Newswire (US)	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2024	NASDAQ:EPIX	ESSA Pharma Inc
2024/05/14	20:00	PR Newswire (Canada)	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2024	NASDAQ:EPIX	ESSA Pharma Inc
2024/05/07	06:17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EPIX	ESSA Pharma Inc
2024/04/09	21:00	PR Newswire (Canada)	ESSA Pharma to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference	NASDAQ:EPIX	ESSA Pharma Inc
2024/04/09	21:00	PR Newswire (US)	ESSA Pharma to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference	NASDAQ:EPIX	ESSA Pharma Inc
2024/03/08	10:13	PR Newswire (Canada)	ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS	NASDAQ:EPIX	ESSA Pharma Inc
2024/03/08	10:13	PR Newswire (US)	ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS	NASDAQ:EPIX	ESSA Pharma Inc
2024/03/08	07:18	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EPIX	ESSA Pharma Inc
2024/03/06	08:50	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EPIX	ESSA Pharma Inc
2024/02/13	21:01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:EPIX	ESSA Pharma Inc
2024/02/13	21:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EPIX	ESSA Pharma Inc
2024/02/13	21:00	PR Newswire (US)	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2023	NASDAQ:EPIX	ESSA Pharma Inc
2024/02/13	21:00	PR Newswire (Canada)	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2023	NASDAQ:EPIX	ESSA Pharma Inc
2024/02/08	01:29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EPIX	ESSA Pharma Inc
2024/02/06	22:27	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EPIX	ESSA Pharma Inc
2024/02/06	22:00	PR Newswire (US)	ESSA Pharma to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference	NASDAQ:EPIX	ESSA Pharma Inc
2024/02/06	22:00	PR Newswire (Canada)	ESSA Pharma to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference	NASDAQ:EPIX	ESSA Pharma Inc
2024/01/29	23:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EPIX	ESSA Pharma Inc
2024/01/27	06:40	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:EPIX	ESSA Pharma Inc
2024/01/27	06:27	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:EPIX	ESSA Pharma Inc
2024/01/26	00:00	PR Newswire (Canada)	ESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the 2024 ASCO Genitourinary Cancers Symposium	NASDAQ:EPIX	ESSA Pharma Inc
2024/01/26	00:00	PR Newswire (US)	ESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the 2024 ASCO Genitourinary Cancers Symposium	NASDAQ:EPIX	ESSA Pharma Inc
2024/01/24	06:09	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:EPIX	ESSA Pharma Inc
2024/01/18	10:57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EPIX	ESSA Pharma Inc
2024/01/17	06:19	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:EPIX	ESSA Pharma Inc
2024/01/17	03:41	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EPIX	ESSA Pharma Inc
2024/01/09	10:06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EPIX	ESSA Pharma Inc
2024/01/06	06:04	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:EPIX	ESSA Pharma Inc

검색 관련기사 보기:NASDAQ:EPIX

1 2 3 4 5 6 7 8 9 10 다음 >>

Nuveen NC Muni Fund

Kols Offering Token

BNP Paribas Issuance

DigiDinar Token

Betashares Capital

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관